Rachael Earnest, MD
Dermatology · Frisco, TXNPI 1306230537
Payments from drug & device makers
Across 401 payments — averaging $21.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Galderma Laboratories, L.p.$1K
- Regeneron Healthcare Solutions, Inc.$540
- Dermavant Sciences, Inc.$501
- Amgen$486
- Pfizer$480
- plus $4K from 29 others
What the payments were for
- Food & beverage$8,36598%
- Education$1952%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 50 | $1,488 |
| Galderma Laboratories, L.p. | 71 | $1,288 |
| Regeneron Healthcare Solutions, Inc. | 21 | $540 |
| Dermavant Sciences, Inc. | 39 | $501 |
| Amgen | 18 | $486 |
| Pfizer | 27 | $480 |
| Sanofi | 11 | $386 |
| Lilly USA, LLC | 11 | $376 |
| Sun Pharmaceutical Industries Inc. | 19 | $338 |
| Boehringer Ingelheim | 6 | $338 |
| Mayne Pharma Commercial LLC | 31 | $335 |
| Johnson & Johnson(2 entities) | 12 | $307 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 14 | $249 |
| Arcutis Biotherapeutics, Inc. | 12 | $206 |
| Organon | 5 | $176 |
| Novartis | 7 | $151 |
| UCB, Inc. | 7 | $133 |
| Incyte Corporation | 8 | $124 |
| LEO Pharma Inc. | 3 | $73 |
| VYNE Pharmaceuticals Inc. | 4 | $72 |
| E.r. Squibb & Sons, L.L.C. | 3 | $58 |
| Boston Scientific | 2 | $57 |
| Kerecis Limited | 1 | $46 |
| Globus Medical | 1 | $45 |
| Dermira, Inc. | 3 | $42 |
| Biofrontera Inc. | 2 | $40 |
| Verrica Pharmaceuticals Inc. | 2 | $37 |
| Almirall LLC | 2 | $34 |
| Botanix SB Inc | 2 | $34 |
| Bristol Myers Squibb | 2 | $29 |
| Mylan Institutional Inc. | 1 | $27 |
| Kyowa Kirin, Inc. | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $16 |
| EPI Health, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,561 in reported general payments places this provider in the 60th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 14 | $56,659 |
| Clobetasol Propionate | 132 | $5,870 |
| Ketoconazole | 165 | $3,229 |
| Triamcinolone Acetonide | 128 | $2,033 |
| Fluorouracil | 32 | $1,817 |
| Clindamycin Phosphate | 46 | $1,104 |
| Tretinoin | 12 | $995 |
| Doxycycline Hyclate | 30 | $547 |
| Mupirocin | 62 | $490 |
| Hydrocortisone | 52 | $464 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Frisco
- Timothy RodgersFrisco$964K
- Stephen TyringWebster$14.1M
- Edward LainAustin$12M
- Mark LeeSan Antonio$10.9M
- John BrowningSan Antonio$10.7M
- Craig TellerBellaire$7.7M
- Patricia LeeWebster$7.2M
- Jennifer CatherDallas$4.9M
- Michael MigdenHouston$3.7M
- Martin MenterDallas$3.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.